{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-21-000144","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.036398+00:00","generated_at":"2026-06-28T17:01:04.942617+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q3: adj EPS $2.20 (+2.8%); organic sales +4.5%; China impairment $105M; guidance revised","bullets":["Net sales $4.2B, +11.3% vs 2020; organic net sales +4.5% vs 2020 and +8.4% vs 2019.","Reported EPS $1.14 (down 30.1%); adjusted EPS $2.20 (up 2.8%) due to $105M impairment.","$105M impairment for China trauma/joint replacement VBP price reductions impacting Orthopaedics.","2021 outlook: organic sales growth 7%-8% from 2019; adj EPS $9.08-$9.15."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-21-000144","json":"https://secwatch.observer/filing/0000310764-21-000144.json","markdown":"https://secwatch.observer/filing/0000310764-21-000144.md","text":"https://secwatch.observer/filing/0000310764-21-000144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076421000144/0000310764-21-000144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076421000144/syk-20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:01:04.942617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}